• BCL6–ESM1 Axis Drives HCC Immune Evasion

  2026-08-27

  Li et al. identify cancer-cell BCL6 as a driver of hepatocellular carcinoma progression that suppresses tumor-infiltrating CD4+ T-cell recruitment and cytotoxicity through ESM1-associated signaling. The study shifts attention beyond CD8+ T cells and provides a mechanistic framework for investigating paracrine immune escape in HCC.

• Firefly Luciferase mRNA: A Signal-First Guide

  2026-08-27

  Firefly Luciferase mRNA is more than a luminescent endpoint: it is a tool for separating transcript quality, delivery, translation, and cell-state effects. This guide uses EZ Cap™ chemistry and recent lipid nanoparticle research to build more interpretable mRNA assays.

• D-Luciferin Potassium Salt for BLI Workflows

  2026-08-26

  D-Luciferin potassium salt supports reproducible firefly luciferase readouts across in vivo cell tracking, promoter studies, and ATP-linked assays. This practical guide connects the product to the VwDODA stress-adaptation study while separating validated bioluminescence workflows from exploratory plant-biology applications.

• PEI MW 40,000 for Stress-Pathway Assays

  2026-08-26

  Polyethylenimine Linear, PEI MW 40,000 can do more than support routine DNA delivery: it can help construct controlled transient gene expression experiments around mitochondrial stress, translation, and barrier biology. This article connects K1029 workflow design with findings from a recent arsenic-induced blood-testis barrier study while emphasizing assay controls and interpretation.

• KU-55933 Workflow for ATM Kinase Inhibition

  2026-08-25

  Build a reproducible KU-55933 workflow around ATM-dependent signaling, phospho-Akt analysis, cell-cycle profiling, and cancer-cell phenotyping. The guide also shows how to use the compound as an exploratory perturbation when studying DNA damage, genome integrity, and the nuclear cGAS–L1 axis.

• Mouse Neutrophil Cell Isolation in Immunotherapy

  2026-08-25

  Neutrophils are moving from experimental bystanders to programmable effectors in cancer immunotherapy. This thought-leadership article explains why activation-conscious mouse neutrophil isolation is strategically important for validating neutrophil-targeted nanovaccines and translating mechanistic findings into reproducible assays.

• 4Q Design for Stable Polymeric mRNA Delivery

  2026-08-24

  Shi and colleagues introduced a “4Q” framework that separates mRNA delivery into vector stability, diffusion, cellular entry, and intracellular release. Their polycatechol PBD system addressed the trade-off between room-temperature storage and cytoplasmic release, producing stable polyplexes and substantially stronger in vivo transfection than a jetPEI/mRNA comparator.

• Ibrexafungerp: Translational Leverage Against Candida

  2026-08-24

  Ibrexafungerp, also known as MK 3118, illustrates how a differentiated glucan synthase mechanism can create translational value beyond conventional susceptibility results. This article connects resistance biology, acidic-pH activity, standardized assay design, delayed-treatment animal models, and clinical strategy to help researchers evaluate the compound with greater rigor and clearer development priorities.

• IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis

  2026-08-23

  The 2025 reference study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage RNA regulation to glycolytic reprogramming and fibrotic polarization in pulmonary fibrosis. Its knockdown, rescue, tissue, and metabolic experiments provide a mechanistic framework for interpreting macrophage contributions to fibrosis while highlighting important limits of the bleomycin model.

• Blebbistatin in Structure–Function Assays

  2026-08-22

  (±)-Blebbistatin is a reversible non-muscle myosin II inhibitor for dissecting force-dependent changes in cell behavior. This guide connects its mechanism and handling with multimodal structure–function imaging, emphasizing assay interpretation, controls, and cross-domain limitations.

• Peptidisc-Assisted Nanobody Multimerization

  2026-08-22

  The reference preprint introduces peptidisc-assisted hydrophobic clustering as a way to assemble nanobodies into soluble multimeric, bispecific, and autofluorescent proteins. Its results indicate that membrane-mimetic stabilization can preserve hydrophobically driven assemblies while improving avidity and expanding nanobody engineering options beyond tandem fusion or scaffold-based designs.

• Cisplatin (CDDP): Workflows for Resistance Studies

  2026-08-21

  Turn Cisplatin (CDDP) into a controlled benchmark for DNA damage, apoptosis, ferroptosis, and chemotherapy resistance studies. This practical guide connects cell viability assays with mechanistic validation and carefully framed xenograft applications.

• Linoleic Acid C18:2: Practical Lab Guide

  2026-08-20

  Linoleic Acid (SKU C3108) provides a defined C18:2(9Z,12Z) input for studying membrane behavior, oxidative stress, epithelial migration, erythrocyte injury, and essential fatty acid biology. It is water-insoluble and should be handled as a freshly prepared ethanol- or DMSO-based solution rather than a long-term aqueous stock.

• Sulfo-NHS-SS-Biotin for Notch Surface Proteomics

  2026-08-20

  Sulfo-NHS-SS-Biotin enables reversible labeling of cell-surface proteins, making it useful for tracking receptor internalization, recycling, and affinity enrichment. Paired with spatial proteomics methods such as TurboID, it can distinguish surface-accessible Notch pools from broader compartment-specific interaction networks.

• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-08-19

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit Plus can support controlled FLCN mRNA rescue assays in Birt-Hogg-Dubé research. This article focuses on assay architecture, transcript quality, controls, and interpretation rather than repeating a general therapeutic workflow.

604 records 1/41 page Next 12345 下5页 Last page